LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Utility of short-interval follow-up mammography after a benign-concordant stereotactic breast biopsy result.

Maldonado, Sean / Gandhi, Nishant / Ha, Tony / Choi, Patrick / Khalkhali, Iraj / Kalantari, Babak N / Dauphine, Christine

Breast (Edinburgh, Scotland)

2018  Volume 42, Page(s) 50–53

Abstract: Background: There is currently no clear consensus recommendation for the use of short-interval follow-up mammography after a benign-concordant breast biopsy (BCBB), and practice patterns vary widely. The objectives of this study were to evaluate whether ...

Abstract Background: There is currently no clear consensus recommendation for the use of short-interval follow-up mammography after a benign-concordant breast biopsy (BCBB), and practice patterns vary widely. The objectives of this study were to evaluate whether a short-interval follow-up mammogram provided clinical utility after stereotactic BCBB and to examine the costs associated with this surveillance strategy.
Methods: A retrospective review of women who underwent a stereotactic breast biopsy yielding benign-concordant results between January 2005 and October 2014 was performed to evaluate findings on subsequent imaging, to calculate compliance with recommended short-interval imaging, and to examine whether subsequent imaging revealed an abnormality at the site of the initial stereotactic BCBB. A cost analysis was performed utilizing Medicare reimbursement rates to calculate projected and actual costs of short-interval follow-up imaging after stereotactic BCBB.
Results: Of the 470 stereotactic BCBB performed, a short-interval mammogram was completed in 207 (44.0%), 9 (4.3%) of which had suspicious mammographic findings at the initial biopsy site, and 6 subsequently underwent biopsy, with none resulting in malignant or high-risk pathology. The cost of short-interval mammographic follow-up (n = 207) was calculated at $28,541.16.
Conclusions: This study provides evidence that 6-month follow-up mammography has low clinical utility and unnecessarily increases costs after stereotactic BCBB. A safe and more cost-effective strategy may be resumption of routine mammography at 12 months post-biopsy.
MeSH term(s) Adult ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/economics ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Early Detection of Cancer/economics ; Early Detection of Cancer/statistics & numerical data ; Female ; Follow-Up Studies ; Humans ; Image-Guided Biopsy/economics ; Image-Guided Biopsy/statistics & numerical data ; Mammography/economics ; Mammography/statistics & numerical data ; Middle Aged ; Neoplasm Staging ; Prognosis ; Retrospective Studies
Language English
Publishing date 2018-08-23
Publishing country Netherlands
Document type Journal Article
ZDB-ID 1143210-x
ISSN 1532-3080 ; 0960-9776
ISSN (online) 1532-3080
ISSN 0960-9776
DOI 10.1016/j.breast.2018.08.101
Shelf mark
Zs.A 3620: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MO 588: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top